"pancreatic tumor progression" trang 4 - tải miễn phí từ tailieunhanh
Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: A retrospective observational study

Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: A retrospective observational study
9    44    1
Relationship between surgical R0 resectability and findings of peripancreatic vascular invasion on CT imaging after neoadjuvant S-1 and concurrent radiotherapy in patients with borderline resectable pancreatic cancer

Relationship between surgical R0 resectability and findings of peripancreatic vascular invasion on CT imaging after neoadjuvant S-1 and concurrent radiotherapy in patients with borderline resectable pancreatic cancer
8    42    1
Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: Separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy

Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: Separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy
12    40    2
Co-sequencing and novel delayed anti-correlation identify function for pancreatic enriched microRNA biomarkers in a rat model of acute pancreatic injury

Co-sequencing and novel delayed anti-correlation identify function for pancreatic enriched microRNA biomarkers in a rat model of acute pancreatic injury
13    60    1
E-cadherin might be a stage-dependent modulator in aggressiveness in pancreatic cancer cells

E-cadherin might be a stage-dependent modulator in aggressiveness in pancreatic cancer cells
8    45    1
Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head

Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head
11    32    1
Multicenter randomized controlled trial and registry study to assess the safety and efficacy of the NanoKnife® system for the ablation of stage 3 pancreatic adenocarcinoma: Overview of study protocols

Multicenter randomized controlled trial and registry study to assess the safety and efficacy of the NanoKnife® system for the ablation of stage 3 pancreatic adenocarcinoma: Overview of study protocols
10    27    1
GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma

GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma
19    50    1
X-ray repair cross-complementing protein 1 (XRCC1) loss promotes β-lapachone – induced apoptosis in pancreatic cancer cells

X-ray repair cross-complementing protein 1 (XRCC1) loss promotes β-lapachone – induced apoptosis in pancreatic cancer cells
11    27    1
KrasG12D induces changes in chromatin territories that differentially impact early nuclear reprogramming in pancreatic cells

KrasG12D induces changes in chromatin territories that differentially impact early nuclear reprogramming in pancreatic cells
29    19    1
Feasibility of administering human pancreatic cancer chemotherapy in a spontaneous pancreatic cancer mouse model

Feasibility of administering human pancreatic cancer chemotherapy in a spontaneous pancreatic cancer mouse model
11    25    1
Co-deficiency of B7-H3 and B7-H4 identifies high CD8+T cell infiltration and better prognosis in pancreatic cancer

Co-deficiency of B7-H3 and B7-H4 identifies high CD8+T cell infiltration and better prognosis in pancreatic cancer
12    14    1
High expression of p62/SQSTM1 predicts shorter survival for patients with pancreatic cancer

High expression of p62/SQSTM1 predicts shorter survival for patients with pancreatic cancer
10    9    1
Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial abutment; a prospective, open-label, phase II study in a single institution

Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial abutment; a prospective, open-label, phase II study in a single institution
11    30    1
A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma

A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
12    1    1
Reduced expression of phosphorylated ataxia-telangiectasia mutated gene is related to poor prognosis and gemcitabine chemoresistance in pancreatic cancer

Reduced expression of phosphorylated ataxia-telangiectasia mutated gene is related to poor prognosis and gemcitabine chemoresistance in pancreatic cancer
13    1    1
The CA125 level postoperative change rule and its prognostic significance in patients with resectable pancreatic cancer

The CA125 level postoperative change rule and its prognostic significance in patients with resectable pancreatic cancer
9    1    1
DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer

DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer
10    5    1
Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistance

Transcriptomic and functional analysis of ANGPTL4 overexpression in pancreatic cancer nominates targets that reverse chemoresistance
13    4    1
Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma

Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma
18    7    1